The global surrogacy market is witnessing significant growth, driven by increasing infertility rates, evolving societal norms, and advancements in assisted reproductive technologies (ART). In 2024, the market was valued at USD 194.0 million and is projected to reach USD 321.4 million by 2033, exhibiting a compound annual growth rate (CAGR) of 5.48% during the forecast period. Factors such as the rise in fertility tourism, affordability of surrogacy services, and supportive legal frameworks across various countries are contributing to this upward trend.

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019–2024
• Forecast Years: 2025–2033 

Surrogacy Market Key Takeaways

• Market Size & Growth: The surrogacy market is projected to grow from USD 194.0 million in 2024 to USD 321.4 million by 2033, reflecting a CAGR of 5.48% during the forecast period.
• Dominant Region: North America leads the market due to supportive legal frameworks and advanced fertility treatment centres.
• Type Preference: Gestational surrogacy is preferred over traditional surrogacy due to legal and ethical considerations.
• Technological Advancements: IVF with ICSI is the most widely used technology in surrogacy procedures.
• Service Provider Trends: Fertility clinics are the primary service providers, offering comprehensive reproductive services.
• Legal Developments: Increasingly clear and supportive legal environments in various countries are facilitating market growth.
• Social Acceptance: Growing societal acceptance of surrogacy, including among LGBTQ+ couples, is contributing to market expansion.

Market Growth Factors

The surrogacy market size expansion is influenced by several key factors:

From IVF to Vitrification: The Technologies Shaping Modern Surrogacy

Advancements in assisted reproductive technology (ART) - such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) - have significantly improved the success rates of surrogacy procedures. These breakthroughs offer greater precision and control throughout the surrogacy journey, resulting in better outcomes for both surrogate mothers and intended parents. Cutting-edge techniques like preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) enable the selection of genetically healthier embryos, reducing the risk of inherited disorders. Additionally, innovations in embryo and egg freezing through vitrification have introduced remarkable flexibility to the surrogacy process, allowing intended parents to preserve fertility and choose the optimal time and surrogate for their family-building goals.

Legal Rights and Protections for Surrogate Mothers: What You Need to Know

Breakthroughs in assisted reproductive technology (ART), including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have dramatically enhanced the success rates of surrogacy procedures. These advancements offer greater precision and control throughout the surrogacy process, leading to improved outcomes for both surrogate mothers and intended parents. Technologies like preimplantation genetic diagnosis (PGD) and screening (PGS) help identify genetically healthier embryos, minimizing the risk of inherited conditions. Additionally, innovations in egg and embryo freezing through vitrification provide unmatched flexibility - allowing families to preserve fertility and plan surrogacy at the most suitable time.

How Fertility Clinics and Agencies Are Raising Awareness About Surrogacy?

The global surrogacy market is witnessing robust growth, driven by increasing awareness and shifting societal attitudes toward alternative paths to parenthood. Greater openness around infertility, LGBTQ+ family rights, and non-traditional family structures is helping to eliminate long-standing stigmas surrounding surrogacy. As more individuals and couples become educated about the legal, medical, and emotional aspects of the process, surrogacy is being embraced as a respected and viable family-building option.

This trend is particularly evident in regions with well-defined legal frameworks that safeguard the rights of both intended parents and surrogate mothers. Celebrity endorsements and public narratives from well-known figures who have chosen surrogacy continue to boost public acceptance and normalize the practice.

Fertility clinics and specialized agencies are also playing a critical role by offering legal support, emotional counseling, and educational resources, empowering families to pursue surrogacy with greater confidence. Together, these factors are fueling consistent expansion in the global surrogacy market.

Request for a sample copy of this report: 

https://www.imarcgroup.com/surrogacy-market/requestsample

Market Segmentation

By Type

• Gestational Surrogacy: In this arrangement, the surrogate carries a child conceived through IVF using the intended parents' or donors' gametes, ensuring no genetic link between the surrogate and the child.
• Traditional Surrogacy: Here, the surrogate's own egg is fertilized, making her the biological mother of the child she carries.

By Technology

• IVF with ICSI: This technique involves injecting a single sperm directly into an egg, commonly used in cases of male infertility.
• IVF without ICSI: Standard IVF procedure where eggs and sperm are combined in a lab dish to allow fertilization.
• Intrauterine Insemination (IUI): A fertility treatment that involves placing sperm directly into a woman's uterus to facilitate fertilization.

By Service Provider

• Hospitals: Medical institutions offering a range of fertility treatments, including surrogacy services.
• Fertility Clinics: Specialized centers focusing on reproductive health and providing comprehensive surrogacy solutions.
• Others: Includes independent surrogacy agencies and consultants offering various support services.

Breakup by Region

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America dominates the surrogacy market, primarily due to its advanced healthcare infrastructure, favorable legal frameworks, and high awareness levels. The United States has well-established surrogacy laws in several states, attracting both domestic and international intended parents seeking reliable and legally secure surrogacy arrangements.

Recent Developments & News

In January 2025, the Supreme Court of India announced its decision to review age restrictions stipulated in the country's surrogacy legislation. The hearing, scheduled for February 11, aims to address concerns regarding the eligibility criteria for intended parents and surrogate mothers. The court emphasized the need for a comprehensive database to prevent the repeated use of the same surrogate and to safeguard against potential exploitation, highlighting the importance of regulatory oversight in the surrogacy process.

Key Players

Bourn Hall Clinic, CARE Fertility, Circle Surrogacy & Egg Donation, Extraordinary Conceptions, Growing Generations LLC, Houston Fertility Center, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Nova IVF, Ovation Fertility, Scanfert Clinic etc.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5298&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145